Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Regulatory News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
Regulatory News
 
NMPA Bans Compound Formulations Containing Furazolidone 2/15/2019
CDE Seeks Comments on Four Draft Chinese Editions of ICH Guidelin... 2/13/2019
CDE Publicizes Information on 62 Newly Approved GQCE Applications... 2/12/2019
CDE Publicizes Two More Drug Applications To Be Granted Priority ... 2/12/2019
SAMR Unveils Its Legislation Plan in 2019 2/3/2019
China Punishes 48 Officials Linked to the Changchun Changsheng Va... 2/3/2019
NMPA Releases List of Reference Formulations for Generic Drug Equ... 1/30/2019
NMPA Suspends Sale and Application of Cheminova’s Imported Aeros... 1/29/2019
The CDE Solicits Feedbacks on the Screening and Determination Pro... 1/28/2019
Review of Chinese Drug Clinical Trial Registration in 2018 1/22/2019
NMPA Holds National Drug Registration and Post-Marketing Regulati... 1/21/2019
Shanghai Introduces Point System for Physician Irregularities 1/16/2019
A New Scandal Involving Expired Polio Vaccine under Investigation... 1/15/2019
NMPA Holds 2018 National Drug Regulation Conference 1/13/2019
CDE Seeks Comments on Draft ICH Guideline E8 and Q3C(R7) 1/8/2019
Snapshot of 404 Drugs Granted Priority Review since 2016 1/3/2019
State Council Issues Interim Order for Local Approval of Drug Imp... 1/2/2019
NMPA Issues Rules for Overseas Inspection of Drugs and Medical De... 12/30/2018
NMPA Publishes Announcement of Generic Drugs Eligible for Exempti... 12/30/2018
NMPA Releases List of Reference Formulations for Generic Drug Equ... 12/30/2018
NMPA Issues Announcement Relating to Generic Quality and Clinical... 12/28/2018
NMPA Issues Notice on Strengthening Drug Regulation During Centra... 12/28/2018
SAMR Issues Amendment of the Provisions for Drug Advertisement Ex... 12/26/2018
CDE Publicizes 36 Drug Applications To Be Granted Priority Review... 12/26/2018
China Issues First Nationwide Negative List, Pledging Equal Treat... 12/25/2018
NMPA Publishes the Second List of Drugs with Expired, Terminated ... 12/24/2018
NMPA Issues the Guidelines for Individual ADR Case Collection and... 12/21/2018
NMPA Solicits Comments on Draft Requirements for Import Drug Stan... 12/20/2018
CDE Seeks Comments on Draft Chinese Translations of 24 ICH Guidel... 12/17/2018
NMPA Seeks Comments on the Second List of Drugs with Expired, Ter... 12/17/2018
Page:1/6    Total number of articles:163  :[1][2][3][4][5][>>][End]

 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links